NIVF vs CYH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

NIVF

53.4
AI Score
VS
NIVF Wins

CYH

52.3
AI Score

Investment Advisor Scores

NIVF

53score
Recommendation
HOLD

CYH

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF CYH Winner
Forward P/E 0.0435 17.6056 NIVF
PEG Ratio 0 2.3833 Tie
Revenue Growth 11.9% -9.8% NIVF
Earnings Growth 0.0% -75.6% NIVF
Tradestie Score 53.4/100 52.3/100 NIVF
Profit Margin 209.0% 2.1% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CYH

Relative Price Performance (Last 90 Days)

NIVF 1M: -52.3% · 3M: -48.1% CYH 1M: +8.3% · 3M: +8.7%

Current Technical Phase

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 38

RSI (14): 38.1 · Price: $0.58

CYH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $3.01

Fundamentals Snapshot

Metric NIVF CYH
Market Cap
Forward P/E 0.0 -5.8
Trailing P/E 0.0 1.6
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.2% 0.4%
Operating Margin -3.5% 0.1%
EPS 108.08 1.89
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.